Kelly Rubin

Kelly received her B.S in Molecular, Cell, and Developmental Biology at UC Santa Cruz. During her undergrad she interned in the Laboratory of Precision Nanomedicine at Tel Aviv University where she developed techniques to utilize Stable Nucleic Acid Lipid Particles (SNALPS) containing siRNA to mediate inner-cell protein expression. After graduating, Kelly worked in the diagnostics industry at Hologic where she supported the development of several assays, including the COVID-19 assay. Kelly then worked at Thermofisher in the cell services department where she helped engineer stable cell lines expressing gene knockouts, over-expression, and mutation.